Stock Rich List
#6744 on the rich list of 14,644 insiders

Abraham Ceesay

Chief Executive Officer at Rapport Therapeutics; Director at Charles River Laboratories International; Director at Pacira BioSciences. Based in Boston, Massachusetts.

$14.1M
in disclosed stock, +$92K (+0.66%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
6744th of 14,644
Companies held
3
Largest holding
RAPP, 92.1% of total
Latest SEC filing
Oct 21, 2026

What the $14.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Rapport Therapeutics RAPP
Common Stock
Directly450,035$23.59$10.6M75.1%Form 4, Oct 21, 2026
Rapport Therapeutics RAPP
Common Stock
Through Ceesay Family Irrevocable Trust81,729$23.59$1.9M13.6%Form 4, Oct 21, 2026
Charles River Laboratories International CRL
Common Stock
Directly2,384$327.93$782K5.5%Form 4, May 8, 2026
Rapport Therapeutics RAPP
Common Stock
Through Dorothy Ceesay Irrevocable Trust20,729$23.59$489K3.5%Form 4, Oct 21, 2026
Pacira BioSciences PCRX
Common Stock
Directly9,039$36.48$330K2.3%Form 4, Sep 4, 2025

Share counts are the amounts Abraham Ceesay reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 21, 2026SoldRAPP2,210$29.16$64KView
Oct 7, 2026SoldRAPP1,147$30.66$35KView
Oct 6, 2026SoldRAPP3,375$32.03$108KView
Sep 23, 2026SoldRAPP43$41.05$2KView
Sep 23, 2026SoldRAPP1,952$39.05$76KView
Sep 23, 2026SoldRAPP215$39.86$9KView
Sep 8, 2026SoldRAPP7,141$45.56$325KView
Sep 8, 2026SoldRAPP1,069$46.01$49KView
Aug 25, 2026SoldRAPP18,921$49.57$938KView
Aug 11, 2026SoldRAPP3,664$46.90$172KView
Aug 11, 2026SoldRAPP19,500$48.04$937KView
Aug 11, 2026SoldRAPP5,794$48.62$282KView
Aug 10, 2026SoldRAPP14,171$45.97$651KView
Aug 10, 2026SoldRAPP8,370$46.75$391KView
Jul 27, 2026SoldRAPP2,203$42.11$93KView
Jul 27, 2026SoldRAPP7$42.74$299View
Jul 14, 2026SoldRAPP2,729$40.57$111KView
Jul 14, 2026SoldRAPP5,481$39.72$218KView
Jun 29, 2026SoldRAPP876$40.34$35KView
Jun 29, 2026SoldRAPP7,344$39.77$292KView
Feb 18, 2026SoldRAPP3,552$29.05$103KView
Feb 18, 2026SoldRAPP2,100$29.80$63KView
Feb 18, 2026SoldRAPP2,983$29.04$87KView
Feb 18, 2026SoldRAPP2,281$29.80$68KView
Jan 20, 2026SoldRAPP5,083$26.11$133KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
6741John M. Donovan
Director, Palo Alto Networks. Bethesda, MD
$14.1M+$853K (+6.42%)
6742Craig Donald Smith
President and CEO PPM America, Jackson Financial. Lansing, MI
$14.1M−$332K (−2.29%)
6743Christopher J. Policinski
Director, Xcel Energy. Indianapolis, IN
$14.1M−$180K (−1.25%)
6744Abraham Ceesay
Chief Executive Officer, Rapport Therapeutics. Boston, MA
$14.1M+$92K (+0.66%)
6745Nicholas Marco Miller
Chief Operating Officer, Nextpower. Fremont, CA
$14.1M−$458K (−3.14%)
6746Andrew A. McKnight
Director, MP Materials. Las Vegas, NV
$14.1M+$274K (+1.97%)
6747Joanne Caruso Zaccaro
Chief Legal & Admin Officer, Jacobs Solutions. Dallas, TX
$14.1M−$243K (−1.69%)

Other Rapport Therapeutics insiders

All RAPP insiders

Questions

How much stock does Abraham Ceesay own?

Abraham Ceesay holds $14,144,838 in listed stock based on SEC filings and current prices, mostly Rapport Therapeutics (RAPP). That ranks 6744th on the Stock Rich List.

Is this Abraham Ceesay's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Abraham Ceesay last buy or sell stock?

The most recent open-market trade on file is a sale of 2,210 RAPP shares on Oct 21, 2026 at $29.16.